Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company posted negative performances for FY21 and FAY22, and then marked improved performance, with streamlining its production facility, that boosted its top and bottom lines. It’s major stakeholder Indrayani Biotech is in limelight post change in management and shift in its business model. Based on annualized FY24 super earnings, the issue appears fully priced. Investors may park funds for the medium to long term. Read detail review...
Dindigul Farm Product Limited peer comparison with similar listed entities. (As on March 31, 2023)
| Company Name | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|
| Dindigul Farm Product Limited | 3.59 | -11.39 | Standalone | |||
| Dodla Dairy Limited | 15.84 | 148.44 | 29.36 | 10.76 | 3.13 | Standalone |
| Parag Milk Foods Ltd | 6.34 | 69.81 | 11.55 | 8.37 | 1.05 | Standalone |
| Modern Dairies Ltd. | 5.21 | -41.06 | 3.61 | -12.64 | -0.46 |
Source:
All the financial information for listed industry peer mentioned above is on a Standalone basis sourced from the Annual Reports/Information of the peer company uploaded on the NSE and BSE website for the year ended March 31, 2023. Source for Dindigul Farm Products Limited: Based on the Restated Financial Statements for the year ended March 31, 2023. P/E Ratio has been computed at the Issue Price.
Notes:
Dindigul Farm Product IPO Reviews, analysis and views by popular members. Read Dindigul Farm Product Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP